fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Metformin treatment associated with improved survival in Ovarian Cancer

Written by | 7 Feb 2013

FDA Highlights by Bruce Sylvester – Women with ovarian cancer and diabetes who took metformin for their diabetes have achieved a better survival rate than patients who did… read more.

Treatment for moderate pain

Written by | 30 Jan 2013

This article has been initiated, funded and reviewed by Mercury Pharma.  The management of moderate pain can be a challenge as it calls for more than simple analgesics… read more.

Longer treatment for male UTI not associated with reduced early or late recurrence risk

Written by | 21 Jan 2013

A study of more than 33,000 outpatient male veterans suggests that a longer duration of antimicrobial treatment of more than seven days for a urinary tract infection (UTI)… read more.

Study shows COPD is not independent risk factor for lung cancer

Written by | 21 Dec 2012

Yet, researchers say lung cancer tests needed when making COPD diagnosis.

Abuse during childhood linked to adult-onset asthma

Written by | 21 Dec 2012

According to a new study from the Slone Epidemiology Center (SEC) at Boston University, African-American women who reported suffering abuse before age 11 had a greater likelihood of… read more.

Evidence-based guidelines enable optimal treatment of common low-back pain

Written by | 21 Dec 2012

While scientific evidence suggests that less is typically more when it comes to diagnosing and treating low-back pain in the US, the number of expensive imaging exams and… read more.

ASH 2012 Report – Novel therapeutic agents provide hope for patients with hard-to-treat blood disorders

Written by | 21 Dec 2012

Encouraging safety and efficacy data on novel and emerging therapies presented at the 54th Annual Meeting of the American Society of Haematology (ASH) signal an important step forward… read more.

ASH 2012 Report – New stem cell research, transplant strategies show promise to improve outcomes, reduce complications

Written by | 21 Dec 2012

Studies of stem cell biology and transplant approaches presented at the 54th Annual Meeting of the American Society of Haematology (ASH) illustrate how the use of advanced modelling… read more.

ASH 2012 Report – New results support bendamustine-rituximab (B-R) combination as first-line treatment in patients with (iNHL) and (MCL)

Written by | 21 Dec 2012

Data demonstrate superior patient outcomes with B-R in first-line treatment of iNHL and MCL, compared with current standard of care.

PRT versus IMRT toxicity in prostate cancer

Written by | 21 Dec 2012

There is no difference between proton radiotherapy (PRT) and intensity-modulated radiotherapy (IMRT) when comparing the toxicity among  patients with prostate cancer at 12 months post-treatment according to a… read more.

Amoxicillin/Clavulanate improves exacerbations in mild-to-moderate COPD

Written by | 14 Dec 2012

by Bruce Sylvester – FDA Highlights – According to a study published online on September 7, 2012 in the American Journal of Respiratory and Critical Care Medicine, treatment… read more.

EAU 2012 Report – Proactive Discussion about BPH

Written by | 6 Nov 2012

It is estimated that as many as 24 million European men aged 50 and over experience bothersome urinary symptoms.1,2 Yet, despite experiencing symptoms, men typically wait nearly two… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.